Ep 25: Dotmatics CEO Thomas Swalla on The State of R&D Software

Vital Signs with Jacob Effron and Nikhil Krishnan

Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences. 

0:00 intro

0:36 getting into healthcare

5:20 what R&D looks like today

8:03 what does Dotmatics do?

13:06 differences in software requirements across biotechs

20:15 bundling vs. “best-of-breed”

23:46 do life sciences need their own data tools?

26:44 incorporating AI into Dotmatics tools

34:38 AI replacing scientists

37:39 how Dotmatics tools can serve companies outside of life sciences

39:50 acquisition strategy

44:43 spaces for innovation in R&D

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada